Skip to main content
Skip to search
Skip to main menu
Skip to footer area
Site Menu
Search
Close Search
Search the Neuroimmunology and Multiple Sclerosis Center site
Search
A-Z
|
Search All UMass Chan Sites
UMass Memorial Medical Center - Multiple Sclerosis Center
Neurology Department
Search
Close Search
Search the Neuroimmunology and Multiple Sclerosis Center site
Search
A-Z
|
Search All UMass Chan Sites
Neuroimmunology and Multiple Sclerosis Center
Our Team
Specialty Care
Research
Research
Clinical Trials
Education & Events
Education & Events
Neuroimmunology Fellowship
Patient Resources
Publications
Additional Resources
UMass Memorial Medical Center - Multiple Sclerosis Center
Neurology Department
Page Menu
Total:
15
results
Multiple sclerosis can be diagnosed solely with dissemination in space: No
Monday, April 15, 2024
Author(s):
Christopher C Hemond,Andrew J Solomon
Source:
Multiple sclerosis (Houndmills, Basingstoke, England)
No abstract
Evaluating the Clinical Utility of Epstein-Barr Virus Antibodies as Biomarkers in Multiple Sclerosis: A Systematic Review
Saturday, February 24, 2024
Author(s):
Abigail Bose,Farnaz Khalighinejad,David C Hoaglin,Christopher C Hemond
Source:
Multiple sclerosis and related disorders
CONCLUSION: Heterogeneous methodology limited generalization and meta-analysis. EBV antibody levels are unlikely to represent prognostic biomarkers in MS. The areas of highest ongoing promise relate to diagnostic exclusion and pharmacodynamic/disease response. Use of EBV antibodies as biomarkers in clinical practice remains additionally limited by lack of methodological precision, reliability, and validation.
Imaging chronic active lesions in multiple sclerosis: a consensus statement
Tuesday, January 16, 2024
Author(s):
Francesca Bagnato,Pascal Sati,Christopher C Hemond,Colm Elliott,Susan A Gauthier,Daniel M Harrison,Caterina Mainero,Jiwon Oh,David Pitt,Russell T Shinohara,Seth A Smith,Bruce Trapp,Christina J Azevedo,Peter A Calabresi,Roland G Henry,Cornelia Laule,Daniel Ontaneda,William D Rooney,Nancy L Sicotte,Daniel S Reich,Martina Absinta
Source:
Brain : a journal of neurology
Chronic active lesions (CAL) are an important manifestation of chronic inflammation in multiple sclerosis (MS) and have implications for non-relapsing biological progression. In recent years, the discovery of innovative magnetic resonance imaging (MRI) and PET derived biomarkers has made it possible to detect CAL, and to some extent quantify them, in the brain of persons with MS, in vivo. Paramagnetic rim lesions on susceptibility-sensitive MRI sequences, MRI-defined slowly expanding lesions on...
Paramagnetic rim lesions are associated with pathogenic CSF profiles and worse clinical status in multiple sclerosis: A retrospective cross-sectional study
Friday, June 24, 2022
Author(s):
Christopher C Hemond,Jonggyu Baek,Carolina Ionete,Daniel S Reich
Source:
Multiple sclerosis (Houndmills, Basingstoke, England)
CONCLUSION: PRLs, an emerging noninvasive biomarker of chronic neuroinflammation, are confirmed to be associated with greater disease severity and newly shown to be preliminarily associated with blood-brain barrier disruption.
The impact of socioeconomic status on mental health and health-seeking behavior across race and ethnicity in a large multiple sclerosis cohort
Saturday, December 25, 2021
Author(s):
Daniela A Pimentel Maldonado,Justin R Eusebio,Lilyana Amezcua,Eleni S Vasileiou,Ellen M Mowry,Christopher C Hemond,Raffaella Umeton Pizzolato,Idanis Berrios Morales,Irina Radu,Carolina Ionete,Kathryn C Fitzgerald
Source:
Multiple sclerosis and related disorders
CONCLUSION: Higher SES was associated with a lower burden of psychiatric symptoms and with a higher likelihood of self-reported symptom recovery after receiving mental health treatment. Attitudes regarding mental health care delivery in MS varied according to racial and ethnic background. Future longitudinal studies in more diverse populations should assess whether co-location of mental health services with MS care helps to reduce the gap between access and need of mental health care in MS.
Paramagnetic Rim Lesions in Multiple Sclerosis: Comparison of Visualization at 1.5-T and 3-T MRI
Wednesday, December 01, 2021
Author(s):
Christopher C Hemond,Daniel S Reich,Sathish K Dundamadappa
Source:
AJR. American journal of roentgenology
BACKGROUND. Multiple sclerosis (MS) is characterized by both acute and chronic intrathecal inflammation. A subset of MS lesions show paramagnetic rims on susceptibility-weighted MRI sequences, reflecting iron accumulation in microglia. These para-magnetic rim lesions have been proposed as a marker of compartmentalized smoldering disease. Paramagnetic rim lesions have been shown at 7 T and, more recently, at 3 T. As susceptibility effects are weaker at lower field strength, it remains unclear if...
Serum Albumin Modifies the Effect of Peripheral Blood Monocytes on Severity of Diabetic Nephropathy in an Adult Population
Monday, August 02, 2021
Author(s):
Cagney Cristancho,Christopher C Hemond
Source:
Canadian journal of diabetes
CONCLUSIONS: Circulating monocytes and serum albumin are significantly associated with albuminuria, but not eGFR in DKD. These results support the potential role of the innate immune system in diabetic microvascular end-organ damage and urinary protein loss, and may be readily translatable clinical markers to incorporate into risk-assessment models for prognostication in diabetes.
Exacerbation of Multiple Sclerosis by BRAF/MEK Treatment for Malignant Melanoma: The Central Vein Sign to Distinguish Demyelinating Lesions From Metastases
Monday, July 26, 2021
Author(s):
Christopher C Hemond,Rohit Bakshi,Shahamat Tauhid,Rosila Sarrosa,Madison Ryan,Vineetha Kamath,James Thomas,Keith R Edwards
Source:
Journal of investigative medicine high impact case reports
The emergence of immunomodulators as effective cancer treatments has been an important advance in cancer therapy. The combination therapy of BRAF/MEK inhibition with or without anti-CTLA-4 treatment causes an immunostimulatory effect that has greatly reduced death from melanoma. In this article, we present the case of a patient with prior multiple sclerosis (MS) and who later developed metastatic malignant melanoma, had a marked increase of magnetic resonance imaging (MRI) findings after...
A real-world cohort analysis of alemtuzumab outcomes in relapsing multiple sclerosis
Saturday, November 14, 2020
Author(s):
Jorge Acevedo Herman,Farnaz Khalighinejad,Katherine York,Irina Radu,Idanis Berrios Morales,Carolina Ionete,Christopher C Hemond
Source:
Multiple sclerosis and related disorders
Multiple sclerosis (MS) is a chronic and progressive neurological disease characterized by recurrent episodes of inflammatory demyelination of the brain and spinal cord. Alemtuzumab has been previously shown in large phase III trials to be an effective therapy in reducing MS clinical flares as well as new radiological activity and atrophy rates. The purpose of this study was to examine real-world effectiveness and safety data from a large cohort of people treated with alemtuzumab at an academic...
Cervical spondylosis is a risk factor for localized spinal cord lesions in multiple sclerosis
Thursday, October 22, 2020
Author(s):
Roberto Bomprezzi,Andrew P Chen,Christopher C Hemond
Source:
Clinical neurology and neurosurgery
CONCLUSIONS: The data from our cohort of MS patients suggest an indirect contribution of cervical spondylosis to disability by increasing the risk of developing localized cord lesions. While further studies are needed to confirm the findings and clarify disease mechanisms, closer attention should be paid to worsening spondylosis in patients with MS.
A paradox of social distancing for SARS-CoV-2: loneliness and heightened immunological risk
Wednesday, August 12, 2020
Author(s):
Liron Rozenkrantz,Michael H Bernstein,Christopher C Hemond
Source:
Molecular psychiatry
No abstract
Placebos in chronic pain: evidence, theory, ethics, and use in clinical practice
Wednesday, July 22, 2020
Author(s):
Ted J Kaptchuk,Christopher C Hemond,Franklin G Miller
Source:
BMJ (Clinical research ed.)
Despite their ubiquitous presence, placebos and placebo effects retain an ambiguous and unsettling presence in biomedicine. Specifically focused on chronic pain, this review examines the effect of placebo treatment under three distinct frameworks: double blind, deception, and open label honestly prescribed. These specific conditions do not necessarily differentially modify placebo outcomes. Psychological, clinical, and neurological theories of placebo effects are scrutinized. In chronic pain,...
HHV-6-Associated Neurological Disease in Children: Epidemiologic, Clinical, Diagnostic, and Treatment Considerations
Wednesday, January 15, 2020
Author(s):
Eva Eliassen,Christopher C Hemond,Jonathan D Santoro
Source:
Pediatric neurology
Human herpesviruses 6A and 6B, often referred to collectively as human herpesvirus 6, are a pair of beta-herpesviruses known to cause a variety of clinical syndromes in both immunocompetent and immunocompromised individuals. Most humans are infected with human herpesvirus 6B, and many with human herpesvirus 6A. Primary infection typically occurs in early childhood, although large-scale reviews on the topic are limited. Herein, the authors explore the clinical manifestations of human herpesvirus...
MRI phenotypes in MS: Longitudinal changes and miRNA signatures
Tuesday, February 26, 2019
Author(s):
Christopher C Hemond,Brian C Healy,Shahamat Tauhid,Maria A Mazzola,Francisco J Quintana,Roopali Gandhi,Howard L Weiner,Rohit Bakshi
Source:
Neurology(R) neuroimmunology & neuroinflammation
CONCLUSIONS: MRI-defined MS phenotypes show high conversion rates characterized by the continuation of either predominant neurodegeneration or inflammation and support the partial independence of these 2 measures. MicroRNA signatures of these phenotypes suggest a role for blood-brain barrier integrity.
The neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios are independently associated with neurological disability and brain atrophy in multiple sclerosis
Thursday, February 14, 2019
Author(s):
Christopher C Hemond,Bonnie I Glanz,Rohit Bakshi,Tanuja Chitnis,Brian C Healy
Source:
BMC neurology
CONCLUSIONS: Elevated NLR and MLR may represent hematopoetic bias toward increased production and pro-inflammatory priming of the myeloid innate immune system (numerator) in conjunction with dysregulated adaptive immune processes (denominator), and consequently reflect a complementary and independent marker for severity of MS-related neurological disability and MRI outcomes.
Back To Top ▲
Close
Our Team
Specialty Care
Research
Research
Clinical Trials
Education & Events
Education & Events
Neuroimmunology Fellowship
Patient Resources
Publications
Additional Resources
UMass Memorial Medical Center - Multiple Sclerosis Center
Neurology Department